Literature DB >> 17394034

Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury.

Rosanna Di Paola1, Salvatore Cuzzocrea.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) belong to a subfamily of transcription nuclear factors. Three isoforms of PPARs have been identified: alpha, beta/delta and gamma, encoded by different genes and distributed in various tissues. They play important roles in metabolic processes like regulation of glucose and lipid redistribution. They also have anti-atherogenic, anti-inflammatory as well as antihypertensive functions. There is good evidence that ligands of PPARs reduce tissue injury associated with ischemia and reperfusion. The potential utility of PPAR ligands in ischemia and reperfusion will be discussed in this review.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17394034     DOI： 10.1007/s00210-007-0141-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


  188 in total

Review 1.  Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family.

Authors:  K Kuwano; N Hara
Journal:  Am J Respir Cell Mol Biol       Date:  2000-02       Impact factor: 6.914

2.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

Authors:  G Wolf; F N Ziyadeh; F Thaiss; J Tomaszewski; R J Caron; U Wenzel; G Zahner; U Helmchen; R A Stahl
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 3.  Endothelial mechanosensors. Going with the flow.

Authors:  J B Lansman
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

4.  Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel.

Authors:  N Sato; F A Moore; B C Kone; L Zou; M A Smith; M A Childs; S Moore-Olufemi; S G Schultz; R A Kozar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-10-27       Impact factor: 4.052

Review 5.  Apoptotic and necrotic cell death induced by death domain receptors.

Authors:  G Denecker; D Vercammen; W Declercq; P Vandenabeele
Journal:  Cell Mol Life Sci       Date:  2001-03       Impact factor: 9.261

Review 6.  Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury.

Authors:  D N Granger
Journal:  Am J Physiol       Date:  1988-12

7.  Anoxia-reoxygenation versus ischemia in isolated rat lungs.

Authors:  G Zhao; A B al-Mehdi; A B Fisher
Journal:  Am J Physiol       Date:  1997-12

8.  Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.

Authors:  G Fragasso; P M Piatti Md; L Monti; A Palloshi; E Setola; P Puccetti; G Calori; G D Lopaschuk; A Margonato
Journal:  Am Heart J       Date:  2003-11       Impact factor: 4.749

Review 9.  Cerebral resuscitation after cardiac arrest: a review.

Authors:  P Safar
Journal:  Circulation       Date:  1986-12       Impact factor: 29.690

10.  Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion.

Authors:  B Vollmar; J Glasz; R Leiderer; S Post; M D Menger
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307
View more
  11 in total

Review 1.  Pathogenesis of acute kidney injury: foundation for clinical practice.

Authors:  Gilbert R Kinsey; Mark D Okusa
Journal:  Am J Kidney Dis       Date:  2011-05-06       Impact factor: 8.860

2.  The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury.

Authors:  Gianluca Miglio; Arianna Carolina Rosa; Lorenza Rattazzi; Cristina Grange; Massimo Collino; Giovanni Camussi; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

3.  Peroxisome proliferator-activated receptor-α staining is associated with worse outcome in colorectal liver metastases.

Authors:  Tony Pang; Antony Kaufman; Julian Choi; Anthony Gill; Martin Drummond; Thomas Hugh; Jaswinder Samra
Journal:  Mol Clin Oncol       Date:  2014-12-30

4.  Activation of beta-adrenoceptors mimics preconditioning of rat-isolated atria and ventricles against ischaemic contractile dysfunction.

Authors:  Peter E Penson; William R Ford; Emma J Kidd; Kenneth J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-29       Impact factor: 3.000

Review 5.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

6.  Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats.

Authors:  Chien-Min Lin; Jo-Ting Tsai; Chen Kuei Chang; Juei-Tang Cheng; Jia-Wei Lin
Journal:  Drug Des Devel Ther       Date:  2015-08-14       Impact factor: 4.162

7.  Antioxidant Stress and Anti-Inflammation of PPARα on Warm Hepatic Ischemia-Reperfusion Injury.

Authors:  Zhixin Gao; Yuan-Hai Li
Journal:  PPAR Res       Date:  2012-11-11       Impact factor: 4.964

8.  Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury.

Authors:  Cheng-Chia Tsai; Kung-Shing Lee; Sheng-Hsien Chen; Li-Jen Chen; Keng-Fan Liu; Juei-Tang Cheng
Journal:  PPAR Res       Date:  2014-04-10       Impact factor: 4.964

9.  PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status.

Authors:  Ying Luo; Qin He; Ge Kuang; Qingsong Jiang; Junqing Yang
Journal:  Behav Brain Funct       Date:  2014-06-16       Impact factor: 3.759

10.  PGC-1α Protects against Hepatic Ischemia Reperfusion Injury by Activating PPARα and PPARγ and Regulating ROS Production.

Authors:  Chaoqun Wang; Zihao Li; Baolei Zhao; Yaohua Wu; Yao Fu; Kai Kang; Yao Li; Liqian Dong; Xiaozhuang Li; Bao Zhang; Huibo Wu; Benqiang Shen; Yanan Xu; Shangha Pan; Hongchi Jiang; Dawei Wang; Yong Ma
Journal:  Oxid Med Cell Longev       Date:  2021-05-19       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.